Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 1 to 5, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 1 to 5, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89 Percent
FRIDAY, Nov. 5, 2021 (HealthDay News) — Pfizer Inc. announced Friday that its experimental COVID-19 pill slashed the risk of hospitalization and death by 89 percent in infected high-risk people.
New U.S. COVID-19 Vaccinations Climb for the Longest Stretch in Months
FRIDAY, Nov. 5, 2021 (HealthDay News) — The number of new COVID-19 vaccinations in the United States rose for eight straight days in late October, the longest period of increases since early August, government data show.
Insulin Rx Fills Down During the Pandemic
FRIDAY, Nov. 5, 2021 (HealthDay News) — There has been a considerable decrease in the average number of weekly insulin prescription fills during the COVID-19 pandemic, according to a research letter published online Nov. 3 in JAMA Network Open.
Heart Attack + COVID-19 Significantly Ups In-Hospital Mortality
FRIDAY, Nov. 5, 2021 (HealthDay News) — Among patients with ST-segment elevation myocardial infarction, a concomitant diagnosis of COVID-19 is associated with significantly higher rates of in-hospital mortality, according to a study published online Oct. 29 in the Journal of the American Medical Association.
More Than 28 Million Excess Years of Life Lost in 2020
FRIDAY, Nov. 5, 2021 (HealthDay News) — In 31 countries, there were more than 28 million excess years of life lost in 2020, according to a study published online Nov. 3 in The BMJ.
Third BNT162b2 Vaccine Dose May Cut Severe COVID-19 Outcomes
FRIDAY, Nov. 5, 2021 (HealthDay News) — Receipt of a third dose of the BNT162b2 mRNA vaccine appears to be effective for reducing severe COVID-19 outcomes compared with receipt of two doses at least five months ago, according to a study published online Oct. 29 in The Lancet.
More Teen Screen Time During Pandemic Tied to Worse Mental Health, Stress
FRIDAY, Nov. 5, 2021 (HealthDay News) — Early in the pandemic, adolescents reported spending nearly eight hours a day on screens, according to a research letter published online Nov. 1 in JAMA Pediatrics.
White House Sets Jan. 4 Deadline for Large, Private U.S. Companies to Mandate Vaccines
THURSDAY, Nov. 4, 2021 (HealthDay News) — Large U.S. companies have until Jan. 4, 2022, to ensure their employees are fully vaccinated against COVID-19, the Biden administration said Thursday.
COVID-19 Widespread Among Iowa Deer
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
.jpeg)
